217 results on '"Sanjurjo-Sáez M"'
Search Results
2. 4CPS-193 Effectiveness and safety of intravenous ustekinumab intensification in Crohn’s disease with loss of response or partial response to subcutaneous therapy
3. P646 Clinical decision support in the prevention of adverse effects associated with immunosuppressive drugs in patients with Inflammatory Bowel Disease
4. Análisis modal de fallos y efectos para mejorar la calidad en los ensayos clínicos
5. Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene
6. 4CPS-013 Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease: efficacy and safety
7. 5PSQ-119 A new pharmaceutical care programme for COVID-19 patients treated with Paxlovid®: Implementation and safety outcomes reported
8. 2SPD-007 Use of drugs in special situations
9. Safe intravenous administration in pediatrics: A 5-year Pediatric Intensive Care Unit experience with smart pumps
10. Prescripciones potencialmente inapropiadas en el tratamiento ambulatorio de pacientes ancianos
11. Eosinophilia secondary to lenalidomide therapy
12. Formación pediátrica para el desarrollo de actividades clínicas
13. 5PSQ-148 TANDEM project: transitions of care and medication reconciliation in high-risk patients
14. 4CPS-095 Appropriateness of empirical antibiotic therapy for cervicitis and urethritis prescribed at the emergency department
15. 4CPS-104 Persistence with disease-modifying therapy in multiple sclerosis patients
16. Indicación de uso de los antirretrovirales de última generación en la práctica clínica actual
17. Indications for the use of next-generation antiretroviral drugs in current clinical practice
18. Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes
19. Impact of the endorse study results on thromboprophylaxis prescribing patterns in medical patients attending the Emergency Department
20. Intervenciones farmacoterapéuticas realizadas mediante un programa de prescripción electrónica en una unidad de medicina interna
21. Analysis of prescriptions given on discharge from the emergencies department. Economic impact
22. 3PC-040 Galenic validation of a dexamethasone 0.01% mouthwash solution to prevent everolimus related stomatitis
23. 1ISG-013 Smartphone applications for patients diagnosed with genitourinary tumours: analysis of the quality using the mobile application rating scale
24. 4CPS-147 Therapeutic positioning and use of intravitreal ranibizumab and aflibercept
25. 4CPS-113 Drug cost saving resulting from metastatic melanoma clinical trials
26. 4CPS-053 Study on daptomycin use as a first step towards an antimicrobial stewardship programme
27. 5PSQ-085 Metabolic disorders in patients treated with second-generation antipsychotics: an opportunity for pharmaceutical intervention
28. 5PSQ-136 A pharmaceutical care programme in patients undergoing cardiac surgery
29. 5PSQ-071 Evaluation of the effectiveness and safety of vedolizumab for the treatment of inflammatory bowel disease
30. Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice
31. Drug cost avoidance in clinical trials of breast cancer
32. 5PSQ-078 Secukinumab for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis in clinical practice
33. Análisis modal de fallos y efectos para mejorar la calidad en los ensayos clínicos
34. Eosinophilia secondary to lenalidomide therapy
35. CP-163 Onco-haematological outpatients treated with oral antineoplastic agents: pharmacist interventions
36. INT-009 Clinical and economic impact of a multidisciplinary intervention to reduce bleeding risk in patients with acute coronary syndrome
37. Drug cost avoidance in clinical trials of breast cancer.
38. Individualized therapy in patients with Fabry disease: is it a feasible strategy for rare diseases?
39. Administración segura de medicamentos intravenosos en pediatría: 5 años de experiencia de una Unidad de Cuidados Intensivos Pediátricos con bombas de infusión inteligentes
40. Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration
41. CP-066 Decreased inr after acenocoumarol and ombitasvir/paritaprevir/ritonavir co-administration
42. CP-085 The impact of pharmacist interventions on safety and cost savings
43. PS-013 Safety programme to avoid skin burns associated with transdermal patches
44. CP-102 Pharmaceutical care monitoring of hepatitis C outpatients: Guaranteeing safety and efficiency
45. DI-054 Safety results of direct acting antivirals for the treatment of hepatitis C virus infection
46. Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes
47. Permanencia del tratamiento antirretroviral de última generación en la práctica clínica diaria
48. Permanencia del tratamiento antirretroviral de última generación en la práctica clínica diaria
49. DI-011 Pharmacist’s role on adherence and literacy in a cancer outpatient setting
50. OHP-013 Cost-effectiness study of cabazitaxel in actual practice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.